Patents
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
09/2009
09/17/2009US20090232747 Thioester compounds and their use in fragrance or flavor applications
09/17/2009US20090232736 Dual specificity antibodies and methods of making and using
09/17/2009DE102008014237A1 Direktverpressbares Tablettierhilfsmittel Direktverpressbares tableting aids
09/17/2009DE102008012295A1 Gemisch zur Herstellung von schnell zerfallenden Tabletten Mixture for the preparation of rapidly disintegrating tablets
09/17/2009CA2718364A1 A topical ectoparasiticide composition
09/17/2009CA2718255A1 Solid dispersion and pharmaceutical composition of the same, and production processes thereof
09/17/2009CA2718244A1 Polyether polyol dendron conjugates with effector molecules for biological targeting
09/17/2009CA2717778A1 Polymer derived from linear polyethylenimine for gene transfer
09/17/2009CA2717699A1 Polyethylene glycolated lactoferrin complex and method of producing the same
09/17/2009CA2717370A1 Biodegradable cross-linked branched poly (alkylene imines)
09/17/2009CA2715585A1 Large particle size crystallised maltitol powder, method for preparing same and applications thereof, particularly in chocolate production
09/17/2009CA2715034A1 Integrin targeting agents and in-vivo and in-vitro imaging methods using the same
09/17/2009CA2713727A1 Carrageenan modified by ion-exchange process
09/16/2009EP2100915A1 Process for production of porous body and uses thereof
09/16/2009EP2100914A1 Method for producing modified biopolymer and method for crosslinking biopolymers
09/16/2009EP2100904A1 Solid phase for use in a method for the purification of albumin conjugates
09/16/2009EP2100901A1 Modified Insulin and conjugates thereof
09/16/2009EP2100620A1 Nucleic acids encoding polyepitope polypeptides
09/16/2009EP2100619A1 Anti-CD70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders
09/16/2009EP2100616A2 Composition of antigen and glycolipid adjuvant sublingual administration
09/16/2009EP2100612A2 Semi-solid mucoadhesive formulations
09/16/2009EP2100600A1 Extended release oral dosage composition
09/16/2009EP2100597A2 Liposome complexes
09/16/2009EP2100596A2 Injectable liquid paracetamol formulation
09/16/2009EP2099847A1 Hydrogel and biomedical applications thereof
09/16/2009EP2099823A2 Variant target binding agents and uses thereof
09/16/2009EP2099523A2 Methods for treating pompe disease
09/16/2009EP2099496A2 Delivery of nanoparticles and/or agents to cells
09/16/2009EP2099495A2 Conjugates of a g-csf moiety and a polymer
09/16/2009EP2099494A2 Multivalent pneumococcal polysaccharide-protein conjugate composition
09/16/2009EP2099493A1 Peptide-based hair protectants
09/16/2009EP2099487A2 Process for manufacturing vaccines
09/16/2009EP2099466A1 Use of hydrolytic and oxidative enzymes to dissolve biofilm in ears
09/16/2009EP2099429A2 Micellar nanoparticles comprising botulinum toxin
09/16/2009EP2099410A2 Compositions comprising macromolecular assemblies of lipid and surfactant
09/16/2009EP2099387A2 Intraocular drug delivery systems
09/16/2009EP1988924B1 New stable hyperbaric composition comprising prilocaine hcl, use of said new composition for intrathecal anaesthesia, and method for manufacturing said composition
09/16/2009EP1893237B1 Pharmaceutical composition comprising an organopolysiloxane elastomer and a solubilized active principle
09/16/2009EP1752142B1 Pegylated nanoparticles
09/16/2009EP1732612B1 Tripartite conjugates containing a structure interacting with cell membrane rafts and their use
09/16/2009EP1605847B1 Antibody-targeted photodynamic therapy
09/16/2009EP1324776B1 Reduced-viscosity concentrated protein formulations
09/16/2009EP1223978B9 Archaeosomes as adjuvants and carriers for acellular vaccines to induce cytotoxic t lymphocyte (ctl) responses
09/16/2009EP1169021B1 Compositions and methods for treating lymphoma
09/16/2009EP1153601B1 Skin preparations for external use
09/16/2009EP0941087B1 Topical formulations containing as a therapeutic active agent a monoglyceride for treating of mucosa infections
09/16/2009CN101534864A Liquid preparation comprising a complex of pimobendan and cyclodextrin
09/16/2009CN101534863A Composition for skin or mucosal application
09/16/2009CN101534862A External preparation for skin
09/16/2009CN101531718A Anti-VEGFR-2 antibody chimeric Fab antibody fragment, preparation method and application thereof
09/16/2009CN101530621A Oxidation resisting dipeptide medicament intercalated houghite and preparation method thereof
09/16/2009CN101530620A Triphosadenine intercalated houghite membrane and preparation method thereof
09/16/2009CN101530619A Method for preparing water soluble pegylation hydroxycamptothecine derivatives
09/16/2009CN101530616A Vaccine adjuvant and vaccine composition
09/16/2009CN101530615A Divalent recombinant human papilla virus vaccine
09/16/2009CN101530614A Pentavalent recombinant human papilla virus vaccine
09/16/2009CN101530612A Type-16 recombinant human papilla virus vaccine
09/16/2009CN101530609A Nanometer Shuxuetong injection preparation and preparation method thereof
09/16/2009CN101530543A Pink reineckia total saponin aerosol
09/16/2009CN101530542A Oral pharmaceutical preparation of chinaroot greenbrier total aglycon and preparation method and application thereof
09/16/2009CN101530534A Oral pharmaceutical preparation of dioscorea panthaica total sapogenin and preparation method and application thereof
09/16/2009CN101530533A Oral pharmaceutical preparation of dioscorea zingiberensis wright total sapogenin and preparation method and application thereof
09/16/2009CN101530532A Oral pharmaceutical preparation of yam total sapogenin and preparation method and application thereof
09/16/2009CN101530509A Swim bladder kidney-reinforcing pill preparation and method for preparing same
09/16/2009CN101530471A Preparation drug of rhinitis of biond magnolia flower and preparation method thereof
09/16/2009CN101530466A Nano medicament containing oregano oil and vitamins
09/16/2009CN101530460A Line products of alcohol-relieving and liver-protecting preparation
09/16/2009CN101530446A General ixeris flavone extract slow-release preparation and application
09/16/2009CN101530444A Soft capsules of volatile oil of chrysanthemum
09/16/2009CN101530440A Oral pharmaceutical preparation of aralia elata total sapogenin and preparation method and application thereof
09/16/2009CN101530421A A Bianque stone paste and a preparation method thereof
09/16/2009CN101530416A Composition containing adefovir dipivoxil, and preparation method thereof
09/16/2009CN101530412A Pharmaceutical composition of blonanserin and preparation method thereof
09/16/2009CN101530403A Xylitol compound for curing or preventing female colpitis and cervical erosion
09/16/2009CN101530402A Silk fibroin multicoat membrane and preparation method thereof
09/16/2009CN101530400A Effervescence tablet capable of treating penis erection dysfunction and preparation method thereof
09/16/2009CN101530399A Silibinin solid self-emusifying tablet and preparation method thereof
09/16/2009CN101530398A Tablet suitable for the administration of children and manufacturing method thereof
09/16/2009CN101530397A Phloroglucinol freeze-dried powder injection composition for injection
09/16/2009CN101530396A Method for preparing an amlodipine microsphere
09/16/2009CN101530395A Method for preparing LTB-carboxymethyl chitosan influenza vaccine intranasal immunization microspheres
09/16/2009CN101530394A Polypeptide-chitosan composite nanoparticles loaded with coenzyme Q10 and preparation method thereof
09/16/2009CN101530393A Clindamycin phosphate lipidosome freeze-dried preparation and preparation method thereof
09/16/2009CN101530392A Omeprazole sodium freeze-dried lipidosome preparation and preparation method thereof
09/16/2009CN101530391A Creatine phosphate sodium lipidosome freeze-dried preparation and preparation method thereof
09/16/2009CN101530390A Preparation of Alpha-linolenic acid nanoliposome preparation and prescription
09/16/2009CN101530388A Formulation of mildronate injection and preparation method
09/16/2009CN101530387A An oral intake slowback pharmaceutic preparation
09/16/2009CN101530386A Gel with the active component being 11-hydroxy-oleanane-28-carboxylic acid methyl ester-2,12-diene
09/16/2009CN100540057C Slow releasing carrier material for implanted medicine and its preparation process
09/16/2009CN100540056C Method for preparing hollow fiber with temperature sensitive medicinal hydrogel and application thereof
09/16/2009CN100540055C Biodegradable block copolymeric compositions for drug delivery
09/16/2009CN100540048C Angiogenesis inducer
09/16/2009CN100540007C Dihydrate dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compositions thereof
09/16/2009CN100540006C Platinum derivative pharmaceutical formulations
09/16/2009CN100539879C Method of inhibiting water content variation of composition and use thereof
09/15/2009US7589169 Carrier with a metal binding domain, a metal ion, and an active agent; e.g., polylysine with a polyoxyethylene side chain with a polyalkylenepolyaminepolyacetic acid bonded to a transition metal ion bonded to a protein or nucleotide; drug delivery
09/15/2009US7589157 Multi-arm block copolymers as drug delivery vehicles
09/15/2009US7589128 Process for preparation of amorphous form of a drug
09/15/2009US7589099 Condensation of 7-t-butoxyiminomethylcamptothecin in position 20 with a cyclopeptide containing the RGD sequence; selective cytotoxic activity on human tumor cell lines; antitumor;